Frank P. Vendetti

1.9k total citations
18 papers, 1.1k citations indexed

About

Frank P. Vendetti is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Frank P. Vendetti has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Oncology and 2 papers in Immunology. Recurrent topics in Frank P. Vendetti's work include DNA Repair Mechanisms (7 papers), Histone Deacetylase Inhibitors Research (7 papers) and Epigenetics and DNA Methylation (7 papers). Frank P. Vendetti is often cited by papers focused on DNA Repair Mechanisms (7 papers), Histone Deacetylase Inhibitors Research (7 papers) and Epigenetics and DNA Methylation (7 papers). Frank P. Vendetti collaborates with scholars based in United States, United Kingdom and Estonia. Frank P. Vendetti's co-authors include Charles M. Rudin, Christopher J. Bakkenist, Thomas P. Conrads, Mark J. O’Connor, Alan Lau, Sandra Schamus, Stephen B. Baylin, John Wrangle, Rosalyn A. Juergens and Steven A. Belinsky and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Frank P. Vendetti

17 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank P. Vendetti United States 11 843 411 195 162 120 18 1.1k
Rajita Vatapalli United States 13 807 1.0× 370 0.9× 236 1.2× 185 1.1× 180 1.5× 21 1.1k
Akriti Kharbanda United States 14 705 0.8× 349 0.8× 141 0.7× 218 1.3× 108 0.9× 14 928
Silvia Pietrobono Italy 13 710 0.8× 294 0.7× 171 0.9× 133 0.8× 67 0.6× 25 904
Minhong Shen China 16 643 0.8× 370 0.9× 207 1.1× 243 1.5× 93 0.8× 25 1.3k
Anja Deutzmann United States 9 608 0.7× 230 0.6× 143 0.7× 189 1.2× 76 0.6× 15 860
Jacqueline Lesperance United States 16 819 1.0× 478 1.2× 248 1.3× 205 1.3× 82 0.7× 25 1.2k
Kandavel Shanmugam United States 13 629 0.7× 509 1.2× 152 0.8× 179 1.1× 139 1.2× 27 1.1k
Peter M.K. Westcott United States 13 631 0.7× 432 1.1× 218 1.1× 319 2.0× 166 1.4× 18 1.0k
Urszula M. Polanska United Kingdom 15 489 0.6× 432 1.1× 104 0.5× 209 1.3× 227 1.9× 29 884
Yuanyan Wei China 20 657 0.8× 373 0.9× 200 1.0× 204 1.3× 56 0.5× 35 949

Countries citing papers authored by Frank P. Vendetti

Since Specialization
Citations

This map shows the geographic impact of Frank P. Vendetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank P. Vendetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank P. Vendetti more than expected).

Fields of papers citing papers by Frank P. Vendetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank P. Vendetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank P. Vendetti. The network helps show where Frank P. Vendetti may publish in the future.

Co-authorship network of co-authors of Frank P. Vendetti

This figure shows the co-authorship network connecting the top 25 collaborators of Frank P. Vendetti. A scholar is included among the top collaborators of Frank P. Vendetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank P. Vendetti. Frank P. Vendetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kiesel, Brian F., Jianxia Guo, Lora H. Rigatti, et al.. (2025). Comparative in vivo toxicology of ATR inhibitors ceralasertib, elimusertib, and berzosertib alone and in combination with ionizing radiation. Toxicology and Applied Pharmacology. 500. 117375–117375.
2.
Vendetti, Frank P., David A. Clump, Meysam Tavakoli, et al.. (2023). The schedule of ATR inhibitor AZD6738 can potentiate or abolish antitumor immune responses to radiotherapy. JCI Insight. 8(4). 17 indexed citations
3.
Sugitani, Norie, Frank P. Vendetti, Tatiana N. Moiseeva, et al.. (2022). Thymidine rescues ATR kinase inhibitor-induced deoxyuridine contamination in genomic DNA, cell death, and interferon-α/β expression. Cell Reports. 40(12). 111371–111371. 10 indexed citations
4.
Sugitani, Norie, Frank P. Vendetti, Tatiana N. Moiseeva, et al.. (2022). ATR Kinase Inhibition Induces Thymineless Death in Proliferating CD8 <sup>+</sup> T Cells. SSRN Electronic Journal. 1 indexed citations
5.
Stabile, Laura P., Vinod Kumar, Eric H.‐B. Huang, et al.. (2020). Syngeneic tobacco carcinogen–induced mouse lung adenocarcinoma model exhibits PD-L1 expression and high tumor mutational burden. JCI Insight. 6(3). 15 indexed citations
6.
Shao, Lulu, Weizhou Hou, Nicole E. Scharping, et al.. (2019). IRF1 Inhibits Antitumor Immunity through the Upregulation of PD-L1 in the Tumor Cell. Cancer Immunology Research. 7(8). 1258–1266. 52 indexed citations
7.
Vendetti, Frank P., David A. Clump, P. T. Teo, et al.. (2018). ATR kinase inhibitor AZD6738 potentiates CD8+ T cell–dependent antitumor activity following radiation. Journal of Clinical Investigation. 128(9). 3926–3940. 141 indexed citations
8.
Vendetti, Frank P., Brian J. Leibowitz, Brian F. Kiesel, et al.. (2017). Pharmacologic ATM but not ATR kinase inhibition abrogates p21-dependent G1 arrest and promotes gastrointestinal syndrome after total body irradiation. Scientific Reports. 7(1). 41892–41892. 16 indexed citations
9.
Kiesel, Brian F., et al.. (2017). LC–MS/MS assay for the simultaneous quantitation of the ATM inhibitor AZ31 and the ATR inhibitor AZD6738 in mouse plasma. Journal of Pharmaceutical and Biomedical Analysis. 138. 158–165. 5 indexed citations
10.
Vendetti, Frank P., Alan Lau, Sandra Schamus, et al.. (2015). The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancerin vivo. Oncotarget. 6(42). 44289–44305. 188 indexed citations
11.
Vendetti, Frank P., Michael J. Topper, Peng Huang, et al.. (2014). Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancer. Oncotarget. 6(1). 56–70. 24 indexed citations
12.
Vendetti, Frank P. & Charles M. Rudin. (2013). Epigenetic therapy in non-small-cell lung cancer: targeting DNA methyltransferases and histone deacetylases. Expert Opinion on Biological Therapy. 13(9). 1273–1285. 53 indexed citations
13.
Wrangle, John, Wei Wang, Alexander Koch, et al.. (2013). Abstract 4619: Epigenetic therapy and sensitization of lung cancer to immunotherapy.. Cancer Research. 73(8_Supplement). 4619–4619. 1 indexed citations
14.
Juergens, Rosalyn A., John Wrangle, Frank P. Vendetti, et al.. (2011). Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung Cancer. Cancer Discovery. 1(7). 598–607. 498 indexed citations
15.
Juergens, Rosalyn A., Frank P. Vendetti, John Wrangle, et al.. (2011). Abstract LB-411: A phase II study of combination epigenetic therapy in advanced non-small cell lung cancer. Cancer Research. 71(8_Supplement). LB–411. 1 indexed citations
16.
Juergens, Rosalyn A., Frank P. Vendetti, Barbara Coleman, et al.. (2009). Interim analysis of a phase II trial of 5-azacitidine (5AC) and entinostat (SNDX-275) in relapsed advanced lung cancer (NSCLC). Journal of Clinical Oncology. 27(15_suppl). 8055–8055. 10 indexed citations
17.
Juergens, Rosalyn A., Frank P. Vendetti, Barbara Coleman, et al.. (2008). Phase I trial of 5-azacitidine (5AC) and SNDX-275 in advanced lung cancer (NSCLC). Journal of Clinical Oncology. 26(15_suppl). 19036–19036. 10 indexed citations
18.
Vendetti, Frank P., et al.. (2006). Differential Actin-dependent Localization Modulates the Evolutionarily Conserved Activity of Shroom Family Proteins. Journal of Biological Chemistry. 281(29). 20542–20554. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rajita Vatapalli Breakdown of academic impact, for papers by Akriti Kharbanda Breakdown of academic impact, for papers by Silvia Pietrobono Breakdown of academic impact, for papers by Minhong Shen Breakdown of academic impact, for papers by Anja Deutzmann Breakdown of academic impact, for papers by Jacqueline Lesperance Breakdown of academic impact, for papers by Kandavel Shanmugam Breakdown of academic impact, for papers by Peter M.K. Westcott Breakdown of academic impact, for papers by Urszula M. Polanska Breakdown of academic impact, for papers by Yuanyan Wei
Rankless by CCL
2026